SCHEMBL2806646

SCHEMBL2806646

CNc1ncc2c(n1)-c1ccccc1C1(CCN(S(=O)(=O)c3ccc(Cl)cc3)CC1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.40
ATM Q13315 1/20 0.40
HSD11B1 P28845 1/20 0.39
POLB P06746 2/20 0.39
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
TSHR P16473 2/20 0.38
USP2 O75604 1/20 0.38
MAPK1 P28482 1/20 0.38
NEK2 P51955 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2802631 0.92 TSHR (0.43) HDAC3HDAC1HDAC2HDAC6SMN1; SMN2
SCHEMBL2802795 0.92 OXTR (0.44) HDAC3HDAC1HDAC2HDAC6SMN1; SMN2
SCHEMBL2806016 0.91 MEN1 (0.40) HDAC3HDAC1HDAC2HDAC6SMN1; SMN2
SCHEMBL2804198 0.91 PKM (0.40) HDAC3HDAC1HDAC2HDAC6SMN1; SMN2
SCHEMBL2804055 0.90 MEN1 (0.40) HDAC3HDAC1HDAC2HDAC6HTT
SCHEMBL2802672 0.90 MEN1 (0.43) ALDH1A1HSD11B1POLBCDK2HTT
SCHEMBL2804994 0.89 PKM (0.42) ALDH1A1HSD11B1HTTUSP2KDM4E
SCHEMBL2804618 0.88 SMN1; SMN2 (0.41) HDAC3HDAC1HDAC2HDAC6SMN1; SMN2
SCHEMBL2808986 0.88 GAA (0.41) SMN1; SMN2ALDH1A1HSD11B1CDK2TSHR
SCHEMBL2808988 0.88 GAA (0.41) SMN1; SMN2ALDH1A1HSD11B1CDK2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HDAC3 1033/4885HDAC1 1006/4885HDAC2 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.